LIXT News and Press, Lixte Biotechnology Holdings Inc. From 12/23/25

--Plans to double the Number of Patients in Study--  --Company Expects Initial Findings to be presented in 2026-- BOCA RATON, Fla., Dec. 23, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), a biotech ...

New York, NY, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Spartan Capital Securities, LLC , a premier investment banking firm, announces its role as exclusive placement agent in a $4.3 million registered direct offering for Lixte Biotechnology Holdings, Inc . (NASDAQ: LIXT). Lixte Biotechnology Holding...

2025-12-18 10:30:15 ET More on Lixte Biotechnology Holdings, Inc. Seeking Alpha’s Quant Rating on Lixte Biotechnology Holdings, Inc. Financial information for Lixte Biotechnology Holdings, Inc. Read the full article on Seeking Alpha For further details...

BOCA RATON, FLA, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a biotech company focused on advancing cancer treatments, today announced that it has entered into definitive agreements in a registered direct offering with accred...

BOCA RATON, FL / ACCESS Newswire / December 8, 2025 / In recent years, LIXTE (NASDAQ:LIXT) has been defined by LB-100, its first-in-class PP2A inhibitor with a mechanism that unlocks new therapeutic angles for resistant cancers. The company built its early identity around that science, and for...

BOCA RATON, FL / ACCESS Newswire / December 3, 2025 / For a micro-cap biotech, the usual headlines bounce between cash raises, compliance updates, and board-room reshuffles. Once in a while, though, one surfaces that sets the stage for something bigger: science that could rewrite the cancer-tr...

BOCA RATON, FL / ACCESS Newswire / December 3, 2025 / Oncology has spent decades chasing the next magic bullet. The twist is that the next breakthrough may not be a bullet at all. It may be an amplifier, the kind of drug that makes every other therapy in the treatment toolbox work harder. LIXT...

Located at the Daresbury site of the renowned UK-based Science and Technology Facilities Council (STFC), with $300+ million invested to date in developing the technology BOCA RATON, Fla., Nov. 25, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or th...

2025-11-10 17:42:14 ET Lixte Biotechnology Holdings, Inc. (LIXT) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 5.46%. The average open to low on the day of earnings was -4.03%. The ave...

2025-11-10 17:37:14 ET Lixte Biotechnology Holdings, Inc. (LIXT) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in LIXT stock price following earnings has averaged ±3.30% , with a median...